CompletedNot Applicable

Effects of Supplementation With Amino Essential Acids on Circulating Albumin Levels in Stroke in Rehabilitation Phase

Italy125 participantsStarted 2018-01-10

Plain-language summary

In addition to its physiological functions, serum albumin plays a role of neuroprotection in cerebrovascular stroke. The circulating levels of albumin may be reduced in patients with stroke due to the presence of a systemic inflammatory state and to the inadequacy of protein-energy intake. The circulating levels of albumin have proven to be predictors of functional recovery in ischemic stroke and cerebral hemorrhage. In the present survey it is hypothesized that it is possible to significantly improve the values of hypoalbuminemia by supplementation with essential amino acids and that, in the second place, any increase in albumin may result in a strengthening of functional recovery in patients with a stroke.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * first episode of cerebral stroke * first taken in rehabilitation after hospitalization in the acute department Exclusion Criteria: * neoplasia * long-term corticosteroid therapy (\> 3 weeks) in the pre-event period and at the time of admission to the rehabilitation department

What they're measuring

Serum Albumin Levels

Timeframe: eight weeks

Trial details

NCT IDNCT04459091

SponsorIstituti Clinici Scientifici Maugeri SpA

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-31

View on ClinicalTrials.gov More Stroke Rehabilitation trials